Psoriasis: open trials in Italy

22 open trials have a site in Italy. Registry data; only the trial team decides who can take part.

NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo · Azienda Unita Sanitaria Locale Di Bologna, Bologna · Ospedale Pediatrico Bambino Gesù, Rome · Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome · Casa Sollievo della Sofferenza, San Giovanni Rotondo · Istituto Di Ricovero E Cura A Carattere Scientifico Materno Infantile Burlo Garofolo, Trieste
Registry updated 2026-11-03
NCT07220824
A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
Research · Janssen Research & Development, LLC
Policlinico di Bari, Bari · ASST Spedali Civili Brescia, Brescia · Hospital Carlo Urbani, Iesi · IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan · ASST Grande Ospedale Metropolitano Niguarda, Milan · San Raffaele Hospital, Milan · Istituto Ortopedico Gaetano Pini, Milan · Seconda Univesità degli Studi di Napoli, AOU, Naples · Azienda Ospedaliera Universitaria Federico II, Naples · Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone, Palermo · Fondazione IRCCS Policlinico San Matteo, Pavia · Università degli Studi di Perugia, Perugia · Ospedale Santa Chiara AO Universitaria Pisana, Pisa · Ospedale San Carlo Di Potenza - Azienda Ospedaliera Regionale, Potenza · Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia · Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma · Policlinico Di Tor Vergata, Roma · A O Universitaria Senese Ospedale Santa Maria alle Scotte, Siena · AO Ordine Mauriziano, Torino · ASST dei Sette Laghi, Ospedale di Circolo e Fonazione Macchi, Varese · Azienda Ospedaliera Universitaria Integrata Verona, Verona
Registry updated 2026-11-03
NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Azienda Ospedaliero - Universitaria di Cagliari, Cagliari · Universita' Degli Studi G. D'Annunzio Di Chieti, Chieti Scalo · Azienda Sanitaria Locale Avezzano Sulmona L'Aquila, L'aquila · Azienda Ospedaliero - Universitaria di Modena, Modena · Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli, Naples · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-10-28
NCT06979453
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico, Bologna · Azienda Ospedaliera Policlinico Universitario Tor Vergata, Rome · Università Cattolica del Sacro Cuore, Rome
Registry updated 2026-10-27
NCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Research · Duke University
IRCCS Ospedale Pediatrico Bambino Gesu (OPBG), Rome
Registry updated 2026-10-21
NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Trial Treatment · Phase 3 · Takeda
Azienda Ospedaliero-Universitaria delle Marche, Ancona · Azienda Ospedaliero-Universitaria Careggi, Florence · Ospedale San Raffaele S.r.l., Milan · Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto, Milan · Azienda Ospedaliera di Padova, Padova · Azienda Ospedaliero Universitaria Pisana, Pisa · Azienda Ospedaliera Policlinico Universitario Tor Vergata, Rome · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-10-14
NCT07039110
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Research · AbbVie
Ospedale San Martino /ID# 278984, Genova · ASL 1 Abruzzo - Ospedale regionale San Salvatore /ID# 277341, L’Aquila · IRCCS Ospedale San Raffaele /ID# 277342, Milan · Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 277713, Naples · Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 278080, Rome
Registry updated 2026-10-01
NCT04638647
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Trial Treatment · Phase 4 · Novartis Pharma AG
Careggi University Hospital, Florence · Azienda USL IRCCS di Reggio Emilia, Reggio Emilia
Registry updated 2026-09-25
NCT07250802
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Trial Treatment · Phase 3 · Takeda
Azienda Ospedaliero-Universitaria Policlinico G. Rodolico-San Marco Di Catania, Catania · Azienda Ospedaliera di Padova, Padova · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Registry updated 2026-09-09
NCT07286058
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Trial Treatment · Phase 3 · Takeda
Azienda Ospedaliero-Universitaria delle Marche, Ancona · Azienda Ospedaliero-Universitaria Careggi, Florence · Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto, Milan · Ospedale San Raffaele S.r.l., Milan · Azienda Ospedaliera di Padova, Padova · Azienda Ospedaliero Universitaria Pisana, Pisa · Azienda Ospedaliera Policlinico Universitario Tor Vergata, Rome · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-09-09
NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Trial Treatment · Phase 3 · AbbVie
Azienda Ospedaliera Universitaria Meyer IRCCS, Florence · Asst Centro Specialistico Ortopedico Traumatologico Gaetano Pini Cto, Milan · Bambino Gesu Childrens Hospital, Rome
Registry updated 2026-09-01
NCT07545902
Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
Trial Treatment · ICIM International S.r.l.
Clinica Dermatologica Dipartimento di Medicina e Scienze dell'Invecchiamento Università G. D' Annunzio, Chieti
Registry updated 2026-07-28
NCT07546032
Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy
Trial Treatment · ICIM International S.r.l.
Clinica Dermatologica Dipartimento di Medicina e Scienze dell'Invecchiamento Università G. D' Annunzio, Chieti
Registry updated 2026-07-28
2023-505121-14-00
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Trial Treatment · Phase 3 · Janssen - Cilag International
Presidio Ospedaliero San Giovanni Di Dio, Cagliari · University Hospital Of Ferrara, Ferrara · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples · Azienda Ospedaliero Universitaria Maggiore della Carità, Novara
Registry updated 2026-07-16
NCT06764693
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Research · AbbVie
Azienda Ospedaliero Universitaria delle Marche /ID# 264636, Ancona · ASST degli Spedali Civili di Brescia /ID# 264699, Brescia · Universita degli Studi del Molise /ID# 265162, Campobasso · AOU Policlinico G. Rodolico - San Marco /ID# 264459, Catania · ASL 2 Abruzzo Lanciano-Vasto-Chieti /ID# 265640, Chieti · ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO /ID# 265161, Milan · IRCCS Ospedale San Raffaele /ID# 266212, Milan · Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 266888, Naples · Azienda Ospedaliero Universitaria Pisana /ID# 264938, Pisa · Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 265145, Rome · IRCCS Istituto Clinico Humanitas /ID# 264463, Rozzano · Azienda Ospedaliera Universitaria Senese /ID# 265207, Siena · ASU FC - P.O. Universitario Santa Maria della Misericordia /ID# 264698, Udine
Registry updated 2026-02-17
NCT07029516
Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis
Trial Treatment · Phase 3 · Wooshin Labottach Co., Ltd.
Clinica Dermatologica - Policlinico - Università degli Studi di Milano Via Francesco Sforza- Milano, Milan
Registry updated 2026-01-26
NCT07336641
LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
Research · Fondazione ISIDE
IRCCS Istituto Clinico Humanitas - Dermatology Unit, Rozzano
Registry updated 2026-01-15
NCT05644782
Dietary Approach to Mild-to-moderate Psoriasis
Trial Treatment · University of Palermo
Dermatology Department of the University Hospital 'P. Giaccone' of Palermo, Italy,, Palermo · Internal Medicine Division of the "Cervello-Villa Sofia" Hospital, Palermo · Internal Medicine Department of the University Hospital of Palermo, Palermo
Registry updated 2026-01-12
NCT06801821
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Research · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia, Roma
Registry updated 2025-08-26
NCT06974474
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Trial Treatment · Phase 4 · Fondazione Policlinico Universitario Campus Bio-Medico
Immunorheumatology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Rome
Registry updated 2025-05-16
NCT06792487
Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)
Research · Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia, Rome
Registry updated 2025-01-24
NCT04359394
International Rare And Severe Psoriasis Expert Network
Research · University Hospital, Basel, Switzerland
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Registry updated 2024-05-09

All Psoriasis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error